The American Society of Clinical Oncology this week urged Congress to take steps to promote interoperability of electronic health records and prevent the practice of “information blocking,” while touting its CancerLinQ initiative that will harness big data analytics, and could potentially help FDA use real-world data to make decisions around medical products. This comes after FDA, the University of Maryland’s Center for Excellence in Regulatory Science Innovation and the Center for Health Information and Decision Systems at a workshop last...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.